Skip to main content
OpenTrials
Completed

NCT Number: NCT05239559

Feasibility and Acceptability Followed by Effectiveness of bCPAP for Treatment of Bangladeshi Children With Severe Pneumonia

Background: Feasibility and acceptability of bubble continuous positive airway pressure (CPAP) were not evaluated in childhood severe pneumonia in developing countries at a larger scale.

Objective:

1. To describe prevailing structural and functional conditions and other operational challenges in nontertiary hospitals in Bangladesh that would need to be addressed in order to introduce bubble CPAP as part of the management of children with severe pneumonia enabling a successful interventional trial. 2. To develop and test bubble CPAP training materials of relevance to clinical staff providing care for children with severe pneumonia in district general hospitals. 3. To determine the prevalence of hypoxaemia among hospitalised children with severe pneumonia in non-tertiary/district hospitals, current practices with regard to management and clinical outcome, to support power calculations of a future interventional trial of bubble CPAP for children with severe pneumonia. 4. To document the early experience, particularly the feasibility and acceptability of introducing bubble CPAP in selected non-tertiary/district hospitals.

Methodology:

Feasibility/demonstration phase will be done as an internal pilot in 2 hospitals. Current treatment practice, facilities, and operational challenges will be evaluated for the introduction, clinical use and maintenance of bubble CPAP.

Outcome:

1. To describe the structural and functional conditions and operational challenges that may influence the introduction of bubble CPAP. 2. To have bubble CPAP training materials that can be delivered cheaply and repeatedly to a level of comprehension of staff providing care to children with pneumonia in district general hospitals in Bangladesh. 3. A quantitative analysis of the incidence of hypoxaemia among hospitalised children with severe pneumonia, current management practices and clinical outcomes. 4. A qualitative assessment of the feasibility of introducing bubble CPAP.

Number of children to be enrolled: 20 children in 2 hospitals as an internal pilot (i.e. 10 in each hospital)

Main inclusion criteria: Age between 2 months and 24 months with severe pneumonia and hypoxemia and guardian/parent gives written informed consent to participate in the study.

Statistical Analysis: For feasibility and acceptability study, a descriptive analysis will be performed.

Study duration: 44 months

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Feasibility Hypoxia Infections Lung Diseases Pathological Conditions, Signs and Symptoms Pneumonia Respiratory Tract Diseases Respiratory Tract Infections Signs and Symptoms Signs and Symptoms, Respiratory

Age range

2 month–24 month

Sex eligibility

All sexes

Study type

Observational

Primary location

Institute of Child and Mother Health, Dhaka, Bangladesh

Loading trial locations.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Staff:
  • Staff (medical and nursing) employed at the two selected hospitals with duties that include care of children with pneumonia
  • Staff who agree to participate and give written informed consent
  • Children for assessment of hypoxaemia in pneumonia and outcomes:
  • Age between 2 - 24 months
  • Attend one of the two study hospitals for the assessment of pneumonia by hospital clinician.
  • Pneumonia defined by WHO criteria
  • Children receiving bubble CPAP:
  • Age between 2 - 24 months.
  • Diagnosis of pneumonia by a hospital clinician together with hypoxaemia (SpO2<90%).
  • Parent/guardian gives informed consent to participate in the study

Exclusion criteria

  • Hospital staff:

o There will be no exclusion criteria

  • Children for assessment of hypoxaemia in pneumonia and outcomes, and children receiving bubble CPAP:
  • Known congenital heart disease, asthma, pulmonary TB and other chronic respiratory disorders

Treatment and study plan

Bubble CPAP oxygen delivery device

Device

In Bubble CPAP, pressurized oxygen from an oxygen cylinder is delivered to the nasopharynx of the baby. An underwater tube (expiratory arm) that acts as a blow off valve is interposed between the oxygen source and the baby. Adjusting the height of the water column above the exit of the tube can regulate the pressure in the system and the amount of CPAP delivered to the baby. The constant bubbling of gas through the blow off mechanism delivers the bubbling CPAP effect. Oxygen may be delivered by nasal prongs inserted into the nostril of child.

The system has three components:

  • Continuous gas flow into the circuit: The gas flow rate required to generate CPAP is usually 5-10 L/min.
  • A nasal interface connecting the child's airway with the circuit:
  • An expiratory arm with the distal end submerged in water to generate end-expiratory pressure.

The source of oxygen will be either an oxygen concentrator or cylinder, central distribution through pipelines.

Primary outcomes

  1. The structural, functional and operational challenges will be described

    Time frame: 44 month

    Human resources, Supply chain, logistics equipment maintenance, power failure, disconnection of oxygen with local complications will be identified.

  2. To have bubble CPAP training materials that can be delivered cheaply and repeatedly to a level of comprehension of staff providing care to children with pneumonia in district general hospitals in Bangladesh

    Time frame: 44 month

    The training module, Standard Operating Procedure, treatment algorithm will be provided to the hospital staff. Hands-on training will be done.

  3. A quantitative analysis of the incidence of hypoxaemia among hospitalised children with severe pneumonia, current management practices and clinical outcomes

    Time frame: 44 month

    Prevalence, management, mortality, referral, discharge, hospital stay, oxygen therapy duration of severe pneumonia cases will be identified.

  4. Feasibility and acceptability of introducing bubble CPAP

    Time frame: 44 month

    Challenges related to the introduction of bCPAP, enrollment, patient management with follow-up recording, human resources, respiratory support will be identified.

Sponsors and collaborators

Lead sponsor

International Centre for Diarrhoeal Disease Research, Bangladesh

Other

Collaborators

  • Directorate General of Health Services, Bangladesh
  • NIHR Global Health Research Unit on Respiratory Health (RESPIRE)
  • University of Edinburgh

Registry information

Official study title

Feasibility and Acceptability Followed by Effectiveness of Bubble Continuous Positive Airway Pressure for Treatment of Bangladeshi Children With Severe Pneumonia

Acronym: Child-bCPAP

Important dates

Study start
2018
Primary completion
2021
Study completion
2021
First posted
Feb 15, 2022
Registry last updated
Feb 15, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.